CTOs on the Move

ProSomnus

www.prosomnus.com

 
ProSomnus is the first manufacturer of precision, mass-customized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus`s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus`s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.prosomnus.com
  • 5675 Gibraltar Drive
    Pleasanton, CA USA 94588
  • Phone: 844.537.5337

Executives

Name Title Contact Details

Similar Companies

AccessClosure, Inc.

AccessClosure, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

New Life Brace and Limb

New Life Brace and Limb is a Webster, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ValenTx

ValenTx was founded with the goal of treating some of the most pervasive health problems of our time: obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. Our approach is to create a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in a highly effective and least-invasive therapy. Current treatments for these diseases include surgery, pharmacology, and medically supervised lifestyle management. The risks, costs, and in some cases poor efficacy of these treatments have hampered their broad adoption by patients, physicians, and payers alike. A truly unmet clinical need exists for a therapy that can deliver the efficacy obtained through surgery, but without the risks and costs associated with surgical intervention. The ValenTx endoluminal bypass therapy mimics the attributes of a Roux-en-Y gastric bypass and is implanted through a non-surgical, endoscopic procedure. This procedure does not require gastric stapling or permanent changes to the patient`s anatomy. The device is removable, replaceable and designed so that the physician could change the therapeutic profile, thereby optimizing the treatment towards the individual patient`s needs. ValenTx has developed a strong intellectual property portfolio, which lies at the foundation of this therapy. The company has successfully conducted a series of clinical studies demonstrating the viability, safety, and efficacy of the therapy.  

Technology Imaging Services

Technology Imaging Services is a Youngstown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Emphasys Medical

Emphasys Medical is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.